Quantum BioPharma announced the results of its annual general and special meeting, including the election of directors and approval of key resolutions such as re-appointing auditors and authorizing share consolidations. The company also closed a private placement of 26 Class A Multiple Voting Shares, raising approximately C$80,860 to support general working capital. This move increases the voting power of Class A shares to about 68.22%, consolidating control among key insiders. The company plans to use the funds for operational purposes and may proceed with a share consolidation and name change as approved by shareholders.
Quantum BioPharma's recent shareholder meeting and private placement are presented here with Pluang's health sector market context as of Nov 11, 2026 19:11 WIB: Among 150 priced health-sector US stocks, 67 rose and 75 fell. Notable movers include TWST (Twist Bioscience Corp) at USD 141.14 with a 1-day change of +6.82% and a typical hold time on Pluang of 27 days, TNGX (Tango Therapeutics Inc.) at USD 23.00 down 5.35% with balanced Pluang order activity, and INMD (InMode Ltd) at USD 13.85 up 4.41% with a typical hold time of 34 days. The most notable figure is TWST's +6.82% daily gain.
NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...
FLSmidth & Co. A/S announced its financial calendar for 2027, including key dates for the annual report, interim financial reports, and the annual general meeting. The company emphasizes its commitment to sustainability with its MissionZero goal to a...
Dimensional Fund Advisors Ltd. has filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc, totaling 12,054,886 shares as of November 10, 2026. This disclosure is part of regulatory requirements under the Takeover Code, indicatin...
Dimensional Fund Advisors Ltd. has filed a disclosure showing it holds a 1.61% stake in DCC Energy plc's ordinary shares as of November 10, 2026. The firm sold 42,998 shares recently at a price of £64.5585 each. This disclosure is part of regulatory ...
Novo Nordisk has committed $200 million to the World Diabetes Foundation for 2027–2036 to enhance diabetes prevention and care in low- and middle-income countries. This funding aims to improve equitable access to diabetes services in underserved comm...
